Turn off MathJax
Article Contents
Cui Lifan,Jin Jian,Wu Hongwei.Preparation of Lip-TTO-PHMB and evaluation of its in vitro antibacterial activity and biocompatibility[J].Chin J Burns Wounds,2026,42(9):1-10.DOI: 10.3760/cma.j.cn501225-20250406-00167.
Citation: Cui Lifan,Jin Jian,Wu Hongwei.Preparation of Lip-TTO-PHMB and evaluation of its in vitro antibacterial activity and biocompatibility[J].Chin J Burns Wounds,2026,42(9):1-10.DOI: 10.3760/cma.j.cn501225-20250406-00167.

Preparation of Lip-TTO-PHMB and evaluation of its in vitro antibacterial activity and biocompatibility

doi: 10.3760/cma.j.cn501225-20250406-00167
Funds:

National Key Research and Development Program of China 2024YFC2420800

More Information
  • Corresponding author: Wu Hongwei, Email: wuhongwei@dhu.edu.cn
  • Received Date: 2025-04-06
    Available Online: 2026-09-09
  •   Objective  To prepare a lecithin liposome-tea tree oil-polyhexamethylene biguanide hydrochloride complex (Lip-TTO-PHMB) and to investigate its in vitro antibacterial activity and biocompatibility.  Methods  This study was an experimental research including group design, factorial design, and repeated measurement design. Lip-TTO-PHMB was prepared by the thin-film hydration method. Through single-factor experiments combined with the Box-Behnken response surface methodology, the optimal preparation condition for Lip-TTO-PHMB was determined as follows: mass ratio of lecithin to cholesterol of 3.77: 1.00, volume fraction of tea tree oil of 0.64%, and volume fraction of polysorbate 80 of 0.13%. The model-predicted encapsulation efficiency was 51.035%. Lip-TTO-PHMB was prepared under the optimal preparation condition and its encapsulation efficiency was measured. Mouse fibroblasts L929 were divided into lecithin liposome-polyhexamethylene biguanide hydrochloride (Lip-PHMB) group, Lip-TTO-PHMB group, and polyhexamethylene biguanide hydrochloride (PHMB) group treated with the corresponding materials, with the final mass concentrations of PHMB adjusted to 62.5, 31.3, and 15.6 μg/L, and the cell viability was detected by the thiazolyl blue tetrazolium bromide assay. Another batch of L929 cells were divided into the same groups as before and treated with the corresponding materials with the final mass concentration of PHMB at 15.0 μg/L, and the cell viability was detected by live/dead cell staining. The sample size for the above experiments was 4. Human immortalized keratinocytes (HaCaT) were divided into control group cultured with serum-free MEM medium, and PHMB group and Lip-TTO-PHMB group treated with the corresponding materials with the final mass concentration of PHMB at 15.0 μg/L. The scratch test was performed to detect the cell migration rates at 24 and 48 h after scratch (with the sample size of 3). The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of PHMB against Staphylococcus aureus ATCC 6538 and Escherichia coli ATCC 8739 were determined by the broth microdilution twofold dilution method, with the sample size of 5.  Results  The measured encapsulation efficiency of Lip-TTO-PHMB was (52.35±0.24)%, which was close to the model-predicted value. After 24 h of culture, at PHMB final mass concentrations of 62.5, 31.3, and 15.6 μg/L, the viability of L929 cells in Lip-PHMB group and Lip-TTO-PHMB group was significantly higher than that in PHMB group (P<0.05), and the viability of L929 cells in Lip-PHMB group was significantly higher than that in Lip-TTO-PHMB group (P<0.05). After 24 h of culture, the viability of L929 cells in PHMB group was significantly lower than that in Lip-PHMB group and Lip-TTO-PHMB group (with P values both<0.05). At 24 and 48 h after scratch, the migration rates of HaCaT cells in Lip-TTO-PHMB group were significantly higher than those in PHMB group (P<0.05); at 48 h after scratch, the migration rate of HaCaT cells in control group was significantly higher than that in PHMB group (P<0.05). The MICs of Lip-PHMB, Lip-TTO-PHMB, and PHMB against Staphylococcus aureus were 31.3, 15.6, and 15.6 μg/mL, respectively, and those against Escherichia coli were 31.3, 15.6, and 7.8 μg/mL, respectively. The MBCs of Lip-PHMB, Lip-TTO-PHMB, and PHMB against Staphylococcus aureus were 20, 10, and 15 μg/mL, respectively, and those against Escherichia coli were 30, 20, and 20 μg/mL, respectively.  Conclusions  The prepared Lip-TTO-PHMB can retain excellent antibacterial activity and possess favorable biocompatibility.

     

  • loading
  • [1]
    Antimicrobial Resistance Collaborators.Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis[J].Lancet,2022,399(10325):629-655.DOI: 10.1016/S0140-6736(21)02724-0.
    [2]
    YeC, LiW, YangY, et al. Inappropriate use of antibiotics exacerbates inflammation through OMV-induced pyroptosis in MDR Klebsiella pneumoniae infection[J]. Cell Rep, 2021, 36(12):109750. DOI: 10.1016/j.celrep.2021.109750.
    [3]
    DeusenberyC,WangY,ShuklaA.Recent innovations in bacterial infection detection and treatment[J].ACS Infect Dis,2021,7(4):695-720.DOI: 10.1021/acsinfecdis.0c00890.
    [4]
    IslamMF, ArkaPB, RohmanM, et al. Pooling the complex survey data across the 64 lower and middle-income countries: a study on antibiotic usage in under-five children[J]. Heliyon, 2024, 11(1):e41470. DOI: 10.1016/j.heliyon.2024.e41470.
    [5]
    孟青,周林涛,陈运生,等.2015-2021年CHINET儿童患者临床分离菌的分布特征和耐药性变迁[J].中国感染与化疗杂志,2025,25(1):48-58.DOI: 10.16718/j.1009-7708.2025.01.008.
    [6]
    金剑PHMB修饰的人工真皮的抗菌能力检测上海海军军医大学2018

    金剑. PHMB修饰的人工真皮的抗菌能力检测[D]. 上海:海军军医大学,2018.

    [7]
    SchuchLF,KirschnickLB,de ArrudaJAA,et al.Malignant peripheral nerve sheath tumour of the oral and maxillofacial region-a systematic review[J].Oral Dis,2022,28(8):2072-2082.DOI: 10.1111/odi.13982.
    [8]
    WorsleyA,VassilevaK,TsuiJ,et al.Polyhexamethylene biguanide:polyurethane blend nanofibrous membranes for wound infection control[J].Polymers (Basel),2019,11(5):915.DOI: 10.3390/polym11050915.
    [9]
    AhaniE, MontazerM, MianehroA, et al. Preparation of long-lasting antibacterial wound dressing through diffusion of cationic-liposome-encapsulated polyhexamethylene biguanide [J]. React Funct Polym, 2021, 169: 105092. DOI: 10.1016/j.reactfunctpolym.2021.105092.
    [10]
    赵玉浩,蒋恩社,刘梦瑶,等.含聚己双胍抗菌剂在慢性伤口治疗与护理中的应用研究进展[J].中华医院感染学杂志,2025,35(21):3355-3360.DOI: 10.11816/cn.ni.2025-246665.
    [11]
    Sowlati-HashjinS,CarboneP,KarttunenM.Insights into the polyhexamethylene biguanide (PHMB) mechanism of action on bacterial membrane and DNA: a molecular dynamics study[J].J Phys Chem B,2020,124(22):4487-4497.DOI: 10.1021/acs.jpcb.0c02609.
    [12]
    杨娜,杨彬,孙文魁,等.皮肤消毒剂开发应用研究进展[J].中国消毒学杂志,2018,35(4):297-300.DOI: 10.11726/j.issn.1001-7658.2018.04.018.
    [13]
    王奎涛,王玉亚,任欢欢,等. 聚六亚甲基双胍消毒剂含量测定方法及消毒效果的研究[J]. 应用化工,2019,48(6):1506-1509. DOI: 10.3969/j.issn.1671-3206.2019.06.056.
    [14]
    俞鑫,王超,夏建明.聚六亚甲基双胍和季铵盐在羊毛抗菌整理中的应用[J].印染,2024,50(5):51-55.DOI: 10.3969/j.yinran.202405006.
    [15]
    BaggaB,GowthamL,AhirwarLK,et al.Outcome of photodynamic therapy with Rose Bengal in conjunction with topical PHMB and chlorhexidine combination in Acanthamoeba keratitis[J].J Ophthalmic Inflamm Infect,2025,15(1):18.DOI: 10.1186/s12348-025-00466-w.
    [16]
    FranchA,KnutssonKA,PedrottiE,et al.Treatment of Acanthamoeba keratitis with high dose PHMB (0.08%) monotherapy in clinical practice: a case series[J].Eur J Ophthalmol,2025,35(4):1235-1241.DOI: 10.1177/11206721241299470.
    [17]
    WangWY, HuHW, ChiouJC, et al. Poly(hexamethylene biguanide) hydrochloride (PHMB)-based materials: synthesis, modification, properties, determination, and application [J]. Polymer Chemistry, 2023, 14(48): 5226. DOI: 10.1039/d3py01148h
    [18]
    SzokaFJr,PapahadjopoulosD.Comparative properties and methods of preparation of lipid vesicles (liposomes)[J].Annu Rev Biophys Bioeng,1980,9:467-508.DOI: 10.1146/annurev.bb.09.060180.002343.
    [19]
    PardiN,HoganMJ,PorterFW,et al.mRNA vaccines - a new era in vaccinology[J].Nat Rev Drug Discov,2018,17(4):261-279.DOI: 10.1038/nrd.2017.243.
    [20]
    WeissigV. From olive oil emulsions to COVID-19 vaccines: liposomes came first [M].New York: Humana,2023: 1-19. DOI: 10.1007/978-1-0716-2954-3_1.
    [21]
    ŠturmL,Poklar UlrihN.Basic methods for preparation of liposomes and studying their interactions with different compounds, with the emphasis on polyphenols[J].Int J Mol Sci,2021,22(12):6547.DOI: 10.3390/ijms22126547.
    [22]
    YangJ, BoerJC, KhongkowM, et al. The development of surface-modified liposomes as an intranasal delivery system for group a streptococcus vaccines[J]. Vaccines (Basel), 2023, 11(2):305. DOI: 10.3390/vaccines11020305.
    [23]
    ThiTTH,SuysEJA,LeeJS,et al.Lipid-based nanoparticles in the clinic and clinical trials: from cancer nanomedicine to COVID-19 vaccines[J].Vaccines (Basel),2021,9(4):359.DOI: 10.3390/vaccines9040359.
    [24]
    HouX,ZaksT,LangerR,et al.Lipid nanoparticles for mRNA delivery[J].Nat Rev Mater,2021,6(12):1078-1094.DOI: 10.1038/s41578-021-00358-0.
    [25]
    GhoshR,DeM.Liposome-based antibacterial delivery: an emergent approach to combat bacterial infections[J].ACS Omega,2023,8(39):35442-35451.DOI: 10.1021/acsomega.3c04893.
    [26]
    孙艺文基于自组装纳米颗粒增强的纤维素基敷料抗菌止血性能研究淄博山东理工大学2025

    孙艺文. 基于自组装纳米颗粒增强的纤维素基敷料抗菌止血性能研究[D]. 淄博:山东理工大学,2025.

    [27]
    LamNS,LongX,SuXZ,et al.Melaleuca alternifolia (tea tree) oil and its monoterpene constituents in treating protozoan and helminthic infections[J].Biomed Pharmacother,2020,130:110624.DOI: 10.1016/j.biopha.2020.110624.
    [28]
    YuanX,CaoD,XiangY,et al.Antifungal activity of essential oils and their potential synergistic effect with amphotericin B[J].Sci Rep,2024,14(1):31125.DOI: 10.1038/s41598-024-82380-0.
    [29]
    李炳霞,张亮.茶树精油的提取及抗耐甲氧西林金黄色葡萄球菌(MRSA)的活性研究[J].山东畜牧兽医,2021,42(6):11-13.DOI: 10.3969/j.issn.1007-1733.2021.06.004.
    [30]
    张瑜,何华名,何聪芬.植物精油抗病毒研究概况[J].中国野生植物资源,2021,40(7):48-54.DOI: 10.3969/j.issn.1006-9690.2021.07.010.
    [31]
    吴克刚,黄洁虹,柴向华,等.植物精油气相清除DPPH自由基的研究[J].中国食品添加剂,2013(3):110-113.DOI: 10.3969/j.issn.1006-2513.2013.03.011.
    [32]
    CulasSM, KaurL, PopovichDG, et al. Physicochemical properties, colloidal stability, and encapsulation efficiency of lecithin-based and chitosan-coated liposomes loaded with Cinnamomum zeylanicum bioactives [J]. Appl Sci, 2026, 16(8):3754. DOI: 10.3390/app16083754.
    [33]
    GadaniM, BadakS, UpadhyayR. Sunflower lecithin-based liposomal formulations of sesbania grandiflora and acerola cherry extracts: enhancing stability and controlled release [J]. International Journal of Biochemistry Research & Review, 2025, 34(5): 186-198. DOI: 10.9734/ijbcrr/2025/v34i51049.
    [34]
    ManY,TangH,WangY,et al.Casein-liposome complex loading basil essential oil: preparation, antibacterial effect, and preservative effect on braised beef[J].Food Chem,2026,511:148807.DOI: 10.1016/j.foodchem.2026.148807.
    [35]
    ZamanW,UllahN,AminA.Rationally engineered essential oil-loaded nanocarriers for acne vulgaris: integrating multiscale molecular modeling, machine learning, and response surface optimization[J].J Microencapsul,2026,43(3):282-313.DOI: 10.1080/02652048.2026.2695092.
    [36]
    KalantariM, AziziK, ShahheidariR, et al. A stable nanoliposomal carboxymethyl cellulose hydrogel of Pelargonium essential oil: formulation, characterization, and enhanced repellent activity against Anopheles stephensi[J]. Parasite Epidemiol Control, 2026, 33:e00490. DOI: 10.1016/j.parepi.2026.e00490.
    [37]
    王洁,陆俊梅,黄晓辰,等.微量MIC检测判断结核分枝杆菌药敏的方法学研究[J].中华检验医学杂志,2010,33(4):315-319.DOI: 10.3760/cma.j.issn.1009-9158.2010.04.006.
    [38]
    AhaniE, MontazerM, MianehroA, et al. Encapsulation of the PHMB with nanoliposome and attachment to wound dressing for long-term antibacterial activity and biocompatibility[J]. World J Microbiol Biotechnol, 2024,40(11):361. DOI: 10.1007/s11274-024-04170-0.
    [39]
    NguyenHL,NguyenHMX,NguyenTBN.Nano-enabled advances in tea tree essential oil (Melaleuca alternifolia): composition, bioactivity, and emerging roles in food protection[J].Materials (Basel),2026,19(13):2915.DOI: 10.3390/ma19132915.
    [40]
    WangH,ZhangH,WangJ,et al.Interfacial co-assembly of CO2-responsive rosin-based surfactant and CNF in gel emulsions for encapsulation and release of tea tree oil[J].Food Chem,2026,509:148580.DOI: 10.1016/j.foodchem.2026.148580.
    [41]
    LinB, WeiW, CaoC, et al. Mechanistic analysis for the inhibition of Staphylococcus aureus by terpinen-4-ol[J]. Nat Prod Commun, 2026, 21(1):1-13. DOI: 10.1177/1934578X251414816.
    [42]
    de AssisKMA,deA Rêgo RI,de MeloDF,et al.Therapeutic potential of Melaleuca alternifolia essential oil in new drug delivery systems[J].Curr Pharm Des,2020,26(33):4048-4055.DOI: 10.2174/1381612826666200305124041.
    [43]
    AlegunO,PandeyaA,CuiJ,et al.Donnan potential across the outer membrane of Gram-negative bacteria and its effect on the permeability of antibiotics[J].Antibiotics (Basel),2021,10(6):701.DOI: 10.3390/antibiotics10060701.
    [44]
    YousefiR, RezaeeY, BayatF, et al. Molecular docking, molecular dynamics simulation, preparation, and characterization of naltrexone-phospholipid complex: a novel cargo with improved loading into multivesicular liposomes [J]. Results in Chemistry, 2024, 9: 101656. DOI: 10.1016/j.rechem.2024.101656.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(6)

    Article Metrics

    Article views (4) PDF downloads(1) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return